Breast surgeons and plastic reconstructive surgeons should work together to care for nerves in the breasts during breast cancer surgery.
A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts.
Research presented at AACR 2023 highlighted a potential new standard of care for NSCLC and other novel treatments for NSCLC and ES-SCLC.
In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.
Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
A recent study suggested that shopping data may help predict the risk of cancer. Now, researchers are exploring the implications of that finding.
Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.
Authors present a concise overview of the diagnosis, risk factors, and treatment of basal cell carcinoma.
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
Studies suggest that ctDNA testing has prognostic value in colorectal cancer, but more research is needed before it can be used in practice.
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.